.png)
10K came out today! Steady increase over previous year is shown. 3 Mill compared to 560 K previous. Some highlights listed below.
https://seekingalpha.com/filing/3833872?uprof=51
A ton to sift through if you are interested...
Few notes from...
Revenues
- Revenues for the year ended September 30, 2017 were $3,021,030 compared to $560,961 for the year ended September 30, 2016. The increase in revenues during the year ended September 30, 2017 is the result of increased testing and consulting services performed in the current year compared to the prior year as well as increased testing services resulted from acquisitions completed during the year ended September 30, 2017 which totaled $1,010,595
Operating Expenses
- Total operating expenses during the year ended September 30, 2017 were $2,635,348 compared to $826,454 during the year ended September 30, 2016. The Company experienced an increase of $1,668,451 in selling, general and administrative expenses during the year ended September 30, 2017 compared to the year ended September 30, 2016 due to higher stock based compensation expenses associated with the employee equity incentive plan and common stock issued for services, along with hiring additional staff to support our sales and marketing activities. Additionally, the Company had a full year of operations from the acquisitions closed during the year ended September 30, 2016 and partial years of operations from the three acquisitions closed during the year ended September 30, 2017. There was an increase of $140,443 in depreciation and amortization recorded in operating expenses which was driven by the amortization of intangible assets associated with the acquisitions completed during the year ended September 30, 2016.
Net Loss
- Net loss during the year ended September 30, 2017 was $3,590,048 compared to $2,552,090 during the year ended September 30, 2016. The increase in net loss is the result of increases in other expenses partially offset by an increase in revenues and gross margins as described above.
There are not many if any other MJ related stocks in the OTC with this kind of transparency or revenues coming in. Revenues and future earnings will only grow from here! Hope folks take a good look at what is being built here! IMO We only go up from this point forward. GLTY
EVIO
https://seekingalpha.com/filing/3833872?uprof=51
A ton to sift through if you are interested...
Few notes from...
Revenues
- Revenues for the year ended September 30, 2017 were $3,021,030 compared to $560,961 for the year ended September 30, 2016. The increase in revenues during the year ended September 30, 2017 is the result of increased testing and consulting services performed in the current year compared to the prior year as well as increased testing services resulted from acquisitions completed during the year ended September 30, 2017 which totaled $1,010,595
Operating Expenses
- Total operating expenses during the year ended September 30, 2017 were $2,635,348 compared to $826,454 during the year ended September 30, 2016. The Company experienced an increase of $1,668,451 in selling, general and administrative expenses during the year ended September 30, 2017 compared to the year ended September 30, 2016 due to higher stock based compensation expenses associated with the employee equity incentive plan and common stock issued for services, along with hiring additional staff to support our sales and marketing activities. Additionally, the Company had a full year of operations from the acquisitions closed during the year ended September 30, 2016 and partial years of operations from the three acquisitions closed during the year ended September 30, 2017. There was an increase of $140,443 in depreciation and amortization recorded in operating expenses which was driven by the amortization of intangible assets associated with the acquisitions completed during the year ended September 30, 2016.
Net Loss
- Net loss during the year ended September 30, 2017 was $3,590,048 compared to $2,552,090 during the year ended September 30, 2016. The increase in net loss is the result of increases in other expenses partially offset by an increase in revenues and gross margins as described above.
There are not many if any other MJ related stocks in the OTC with this kind of transparency or revenues coming in. Revenues and future earnings will only grow from here! Hope folks take a good look at what is being built here! IMO We only go up from this point forward. GLTY
EVIO
